2032 年晶片實驗室市場預測：按產品、材料、技術、應用、最終用戶和地區進行的全球分析

根據 Stratistics MRC 的數據，全球晶片實驗室市場預計在 2025 年達到 73 億美元，到 2032 年將達到 155 億美元，預測期內的複合年成長率為 11.3%。

晶片實驗室是一種緊湊型分析設備，將多個實驗室流程整合到單一微流體平台上。這些系統效率高，能夠以極少的樣本需求快速進行生化和分子生物學分析。透過簡化診斷程序、藥物檢測和環境監測，它們在提供準確結果的同時，最佳化了資源消耗。其自動化功能和即時檢測能力增強了生物醫學研究和即時診斷應用。

對照護現場（POC）的需求不斷成長

微型分析儀提供快速且準確的檢測，無需進行大量檢測，並有助於立即做出醫療決策。隨著慢性病的增多，臨床醫生需要高效的診斷解決方案，以確保及時介入。晶片實驗室系統提供了一種經濟高效且易於使用的傳統診斷方法替代方案，使其成為遠距和分散醫療環境中不可或缺的醫療方案。

複雜的設計與製造挑戰

先進的微流體系統需要精密的工程設計和專用材料，增加了開發成本。在單一晶片上整合多種測試功能需要極高的製造精度，這給大規模生產帶來了障礙。此外，確保與現有診斷工作流程的兼容性在技術上也極具挑戰性，阻礙了市場的成長。

新的器官晶片和人體晶片模型

新的創新平台能夠重現生理狀態，使研究人員能夠更有效地研究疾病機制和治療反應。採用微工程組織的晶片實驗室設備能夠預測藥物療效，並減少對動物試驗的依賴。製藥公司和研究機構正在投資先進的晶片模型，以加速臨床試驗和個人化醫療的發展。

與傳統測試設備的競爭

與傳統檢測設備的競爭對晶片實驗室在某些領域的應用構成了挑戰。集中式分析儀和自動化實驗室系統等成熟的診斷工具憑藉其高通量和標準化的方案，仍然在臨床領域佔據主導地位。醫療保健提供者可能出於對準確性、監管核准以及與現有基礎設施整合方面的擔憂，不願轉向基於晶片的平台。

COVID-19的影響：

疫情凸顯了快速分散診斷的重要性，並引發了人們對晶片實驗室技術的興趣。對能夠高效檢測感染疾病並減少對集中式實驗室依賴的可攜式檢測解決方案的需求激增。研發工作正在加速推進，以開發高靈敏度、快速的COVID-19診斷晶片，進而提升疾病監測能力。然而，供應鏈中斷影響了生產進度，暫時減緩了市場擴張。

試劑和耗材部分預計將在預測期內成為最大的部分

預計在預測期內，試劑和耗材領域將佔據最大的市場佔有率，這得益於晶片實驗室運作所必需的化學成分的穩定需求。這些材料有助於微流體系統內的樣品製備、生化反應和分析過程。晶片實驗室設備在診斷實驗室、藥物研究和環境監測領域的應用日益廣泛，推動了試劑消耗的穩定成長。

預計微流體技術領域在預測期內將實現最高的複合年成長率。

預計在預測期內，微流體技術領域將實現最高成長率，這得益於基於晶片的分析系統的進步。微流體創新最佳化了流體處理、反應動力學和多重檢測，從而提高了診斷的準確性和效率。奈米技術與人工智慧主導的自動化相結合將進一步增強微流體的性能，擴大其在生物醫學應用中的作用。

佔比最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其強大的醫療基礎設施、大量的科研投入以及先進診斷技術的廣泛應用。該地區對精準醫療和分散式檢查的高度重視，使得晶片實驗室解決方案在臨床和製藥領域備受矚目。監管機構的支持以及微流體技術的持續創新，進一步鞏固了北美在全球市場的領先地位。

複合年成長率最高的地區：

在預測期內，由於醫療保健可近性的提高、技術進步以及生物醫學研究舉措的不斷擴展，預計亞太地區將呈現最高的複合年成長率。政府對診斷創新的資助以及個人化醫療的興起正在刺激對晶片實驗室技術的需求。生物技術產業的發展，尤其是在中國、日本和印度，正在推動市場成長，使亞太地區成為下一代診斷發展的活躍中心。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

• 公司簡介
  • 全面分析其他市場參與者（最多 3 家公司）
  • 主要企業的SWOT分析（最多3家公司）
• 地理細分
  • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 研究範圍
• 調查方法
  • 資料探勘
  • 數據分析
  • 數據檢驗
  • 研究途徑
• 研究材料
  • 主要研究資料
  • 次級研究資訊來源
  • 先決條件

第3章市場走勢分析

• 驅動程式
• 限制因素
• 機會
• 威脅
• 產品分析
• 技術分析
• 應用分析
• 最終用戶分析
• 新興市場
• COVID-19的影響

第4章 波特五力分析

• 供應商的議價能力
• 買家的議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭對手之間的競爭

第5章 全球晶片實驗室市場（按產品）

• 試劑和耗材
  • 微流體晶片/墨盒
  • 珠子和顆粒
  • 檢測試劑
  • 緩衝液和溶液
• 裝置
  • 樣品製備單元
  • 整合 LOC 系統
  • 配件
• 軟體和服務
  • 數據分析軟體
  • 自動化和控制軟體
  • 雲端基礎的解決方案
  • 客製化晶片設計和製造服務
  • 維護和支援服務
  • 培訓和諮詢服務

第6章 全球晶片實驗室市場（依材料）

• 聚合物
• 玻璃
• 矽
• 紙
• 其他材料

第7章 全球晶片實驗室市場（按技術）

• 微流體
• 光學技術
• 電化學技術
• 微陣列
• 組織生物晶片/器官晶片
• 其他技術

第8章 全球晶片實驗室市場（按應用）

• 臨床診斷
• 藥物研發
• 基因組學和蛋白​​質組學
• 環境監測
• 食品安全和品管
• 其他用途

第9章 全球晶片實驗室市場（按最終用戶）

• 醫院和診斷中心
• 生物技術和製藥公司
• 學術研究所
• 法醫學研究所
• 其他最終用戶

第 10 章 全球晶片實驗室市場（按地區）

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東和非洲地區

第11章 重大進展

• 協議、夥伴關係、合作和合資企業
• 收購與合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第12章 公司概況

• Becton, Dickinson and Company
• PerkinElmer, Inc.
• Bio-Rad Laboratories
• Agilent Technologies, Inc.
• Thermo Fisher Scientific
• Siemens Healthcare
• Abaxis Inc.
• Roche Diagnostics
• Abbott Laboratories
• Danaher Corporation
• Fluidigm Corporation
• Micronit BV
• Illumina Inc.
• Phalanx Biotech Group Inc.
• bioMerieux SA
• Qiagen NV
• Merck KGaA
• Cepheid Inc.
• IDEX Corporation

According to Stratistics MRC, the Global Lab-on-a-chip Market is accounted for $7.3 billion in 2025 and is expected to reach $15.5 billion by 2032 growing at a CAGR of 11.3% during the forecast period. Lab-on-a-chip is a compact analytical device that integrates multiple laboratory processes into a single microfluidic platform. Designed for efficiency, these systems enable rapid biochemical and molecular analysis with minimal sample requirements. By streamlining diagnostic procedures, drug testing, and environmental monitoring, they optimize resource consumption while delivering precise results. Their automated functionality and real-time detection capabilities enhance biomedical research and point-of-care applications.

Market Dynamics:

Driver:

Growing demand for point-of-care (POC) diagnostics

The miniaturized analytical devices offer rapid, precise testing, eliminating the need for extensive laboratory procedures and facilitating immediate medical decisions. With rising prevalence of chronic diseases, clinicians require efficient diagnostic solutions that ensure timely interventions. Lab-on-a-chip systems provide cost-effective, user-friendly alternatives to conventional diagnostic methods, making them indispensable in remote and decentralized healthcare settings.

Restraint:

Complex design and fabrication challenges

Advanced microfluidic systems require precise engineering and specialized materials, increasing development costs. The integration of multiple laboratory functions on a single chip demands high manufacturing accuracy, creating barriers for mass production. Additionally, ensuring compatibility with existing diagnostic workflows presents technical difficulties which hampers the market growth.

Opportunity:

Emerging organ-on-a-chip and human-on-a-chip models

Emerging innovative platforms replicate physiological conditions, allowing researchers to study disease mechanisms and therapeutic responses more efficiently. Lab-on-a-chip devices equipped with microengineered tissues offer predictive insights into drug efficacy, reducing dependency on animal testing. Pharmaceutical companies and research institutions are investing in advanced chip-based models to accelerate clinical trials and personalized medicine initiatives.

Threat:

Competition from traditional lab instruments

Competition from traditional laboratory instruments poses a challenge to lab-on-a-chip adoption in certain sectors. Established diagnostic tools, such as centralized analyzers and automated lab systems, continue to dominate clinical settings due to their high throughput and standardized protocols. Healthcare providers may hesitate to shift towards chip-based platforms, citing concerns about accuracy, regulatory approvals, and integration with existing infrastructure.

Covid-19 Impact:

The pandemic underscored the significance of rapid and decentralized diagnostics, boosting interest in lab-on-a-chip technology. Demand surged for portable testing solutions that could detect infections efficiently, reducing reliance on centralized laboratories. Research efforts accelerated to develop COVID-19 diagnostic chips with high sensitivity and speed, improving disease surveillance capabilities. However, supply chain disruptions affected manufacturing timelines, temporarily slowing market expansion.

The reagents & consumables segment is expected to be the largest during the forecast period

The reagents & consumables segment is expected to account for the largest market share during the forecast period driven by consistent demand for essential chemical components in lab-on-a-chip operations. These materials facilitate sample preparation, biochemical reactions, and analytical processes within microfluidic systems. The expanding use of lab-on-a-chip devices in diagnostic laboratories, pharmaceutical research, and environmental monitoring reinforces steady growth in reagent consumption.

The microfluidics technology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the microfluidics technology segment is predicted to witness the highest growth rate fueled by advancements in chip-based analytical systems. Microfluidic innovations optimize fluid handling, reaction kinetics, and multiplexed testing, improving diagnostic accuracy and efficiency. The integration of nanotechnology and AI-driven automation further enhances microfluidic capabilities, expanding its role in biomedical applications.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to strong healthcare infrastructure, extensive research investments, and widespread adoption of advanced diagnostics. The region's emphasis on precision medicine and decentralized testing contributes to the prominence of lab-on-a-chip solutions in clinical and pharmaceutical settings. Regulatory support and ongoing innovation in microfluidics further reinforce North America's leadership in the global market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by increasing healthcare access, technological advancements, and growing biomedical research initiatives. Government funding for diagnostics innovation and the rise of personalized medicine are stimulating demand for lab-on-a-chip technology. Expanding biotech industries, particularly in China, Japan, and India, are driving market growth, positioning Asia Pacific as a dynamic hub for next-generation diagnostic development.

Key players in the market

Some of the key players in Lab-on-a-chip Market include Becton, Dickinson and Company, PerkinElmer, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Thermo Fisher Scientific, Siemens Healthcare, Abaxis Inc., Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Fluidigm Corporation, Micronit BV, Illumina Inc., Phalanx Biotech Group Inc., bioMerieux SA, Qiagen NV, Merck KGaA, Cepheid Inc., and IDEX Corporation.

Key Developments:

In May 2025, Thermo Fisher Scientific introduced next-generation MS platforms delivering up to 35% faster scan speed and 50% higher multiplexing capacity to accelerate multi-omics and precision medicine research. These tools enhance Thermo Fisher's proteomics portfolio and support breakthroughs in cancer and Alzheimer's studies.

In May 2025, Illumina Inc. Launched DRAGEN v4.4 with enhanced structural variant detection (~30% improvement), new oncology apps, and AWS F2 cloud support. This update improves performance and scalability for clinical and research-grade genomic pipelines.

In May 2025, Danaher Corporation announced a collaboration to develop AI-powered diagnostics and digital tools to enhance clinical insights and patient outcomes. This partnership bridges Danaher's diagnostics reach with AstraZeneca's therapeutic expertise

Products Covered:

• Reagents & Consumables
• Instruments
• Software & Services

Materials Covered:

• Polymers
• Glass
• Silicon
• Paper
• Other Materials

Technologies Covered:

• Microfluidics Technology
• Optical Technology
• Electrochemical Technology
• Microarrays
• Tissue Biochip / Organ-on-a-chip
• Other Technologies

Applications Covered:

• Clinical Diagnostics
• Drug Discovery & Development
• Genomics & Proteomics
• Environmental Monitoring
• Food Safety & Quality Control
• Other Applications

End Users Covered:

• Hospitals & Diagnostic Centers
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Forensic Laboratories
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Lab-on-a-chip Market, By Product

• 5.1 Introduction
• 5.2 Reagents & Consumables
  • 5.2.1 Microfluidic Chips/Cartridges
  • 5.2.2 Beads & Particles
  • 5.2.3 Detection Reagents
  • 5.2.4 Buffers & Solutions
• 5.3 Instruments
  • 5.3.1 Sample Preparation Units
  • 5.3.2 Integrated LOC Systems
  • 5.3.3 Accessories
• 5.4 Software & Services
  • 5.4.1 Data Analysis Software
  • 5.4.2 Automation & Control Software
  • 5.4.3 Cloud-based Solutions
  • 5.4.4 Custom Chip Design & Fabrication Services
  • 5.4.5 Maintenance & Support Services
  • 5.4.6 Training & Consultation Services

6 Global Lab-on-a-chip Market, By Material

• 6.1 Introduction
• 6.2 Polymers
• 6.3 Glass
• 6.4 Silicon
• 6.5 Paper
• 6.6 Other Materials

7 Global Lab-on-a-chip Market, By Technology

• 7.1 Introduction
• 7.2 Microfluidics Technology
• 7.3 Optical Technology
• 7.4 Electrochemical Technology
• 7.5 Microarrays
• 7.6 Tissue Biochip / Organ-on-a-chip
• 7.7 Other Technologies

8 Global Lab-on-a-chip Market, By Application

• 8.1 Introduction
• 8.2 Clinical Diagnostics
• 8.3 Drug Discovery & Development
• 8.4 Genomics & Proteomics
• 8.5 Environmental Monitoring
• 8.6 Food Safety & Quality Control
• 8.7 Other Applications

9 Global Lab-on-a-chip Market, By End User

• 9.1 Introduction
• 9.2 Hospitals & Diagnostic Centers
• 9.3 Biotechnology & Pharmaceutical Companies
• 9.4 Academic & Research Institutes
• 9.5 Forensic Laboratories
• 9.6 Other End Users

10 Global Lab-on-a-chip Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Becton, Dickinson and Company
• 12.2 PerkinElmer, Inc.
• 12.3 Bio-Rad Laboratories
• 12.4 Agilent Technologies, Inc.
• 12.5 Thermo Fisher Scientific
• 12.6 Siemens Healthcare
• 12.7 Abaxis Inc.
• 12.8 Roche Diagnostics
• 12.9 Abbott Laboratories
• 12.10 Danaher Corporation
• 12.11 Fluidigm Corporation
• 12.12 Micronit BV
• 12.13 Illumina Inc.
• 12.14 Phalanx Biotech Group Inc.
• 12.15 bioMerieux SA
• 12.16 Qiagen NV
• 12.17 Merck KGaA
• 12.18 Cepheid Inc.
• 12.19 IDEX Corporation

List of Tables

• Table 1 Global Lab-on-a-chip Market Outlook, By Region (2024-2032) ($MN)
• Table 2 Global Lab-on-a-chip Market Outlook, By Product (2024-2032) ($MN)
• Table 3 Global Lab-on-a-chip Market Outlook, By Reagents & Consumables (2024-2032) ($MN)
• Table 4 Global Lab-on-a-chip Market Outlook, By Microfluidic Chips/Cartridges (2024-2032) ($MN)
• Table 5 Global Lab-on-a-chip Market Outlook, By Beads & Particles (2024-2032) ($MN)
• Table 6 Global Lab-on-a-chip Market Outlook, By Detection Reagents (2024-2032) ($MN)
• Table 7 Global Lab-on-a-chip Market Outlook, By Buffers & Solutions (2024-2032) ($MN)
• Table 8 Global Lab-on-a-chip Market Outlook, By Instruments (2024-2032) ($MN)
• Table 9 Global Lab-on-a-chip Market Outlook, By Sample Preparation Units (2024-2032) ($MN)
• Table 10 Global Lab-on-a-chip Market Outlook, By Integrated LOC Systems (2024-2032) ($MN)
• Table 11 Global Lab-on-a-chip Market Outlook, By Accessories (2024-2032) ($MN)
• Table 12 Global Lab-on-a-chip Market Outlook, By Software & Services (2024-2032) ($MN)
• Table 13 Global Lab-on-a-chip Market Outlook, By Data Analysis Software (2024-2032) ($MN)
• Table 14 Global Lab-on-a-chip Market Outlook, By Automation & Control Software (2024-2032) ($MN)
• Table 15 Global Lab-on-a-chip Market Outlook, By Cloud-based Solutions (2024-2032) ($MN)
• Table 16 Global Lab-on-a-chip Market Outlook, By Custom Chip Design & Fabrication Services (2024-2032) ($MN)
• Table 17 Global Lab-on-a-chip Market Outlook, By Maintenance & Support Services (2024-2032) ($MN)
• Table 18 Global Lab-on-a-chip Market Outlook, By Training & Consultation Services (2024-2032) ($MN)
• Table 19 Global Lab-on-a-chip Market Outlook, By Material (2024-2032) ($MN)
• Table 20 Global Lab-on-a-chip Market Outlook, By Polymers (2024-2032) ($MN)
• Table 21 Global Lab-on-a-chip Market Outlook, By Glass (2024-2032) ($MN)
• Table 22 Global Lab-on-a-chip Market Outlook, By Silicon (2024-2032) ($MN)
• Table 23 Global Lab-on-a-chip Market Outlook, By Paper (2024-2032) ($MN)
• Table 24 Global Lab-on-a-chip Market Outlook, By Other Materials (2024-2032) ($MN)
• Table 25 Global Lab-on-a-chip Market Outlook, By Technology (2024-2032) ($MN)
• Table 26 Global Lab-on-a-chip Market Outlook, By Microfluidics Technology (2024-2032) ($MN)
• Table 27 Global Lab-on-a-chip Market Outlook, By Optical Technology (2024-2032) ($MN)
• Table 28 Global Lab-on-a-chip Market Outlook, By Electrochemical Technology (2024-2032) ($MN)
• Table 29 Global Lab-on-a-chip Market Outlook, By Microarrays (2024-2032) ($MN)
• Table 30 Global Lab-on-a-chip Market Outlook, By Tissue Biochip / Organ-on-a-chip (2024-2032) ($MN)
• Table 31 Global Lab-on-a-chip Market Outlook, By Other Technologies (2024-2032) ($MN)
• Table 32 Global Lab-on-a-chip Market Outlook, By Application (2024-2032) ($MN)
• Table 33 Global Lab-on-a-chip Market Outlook, By Clinical Diagnostics (2024-2032) ($MN)
• Table 34 Global Lab-on-a-chip Market Outlook, By Drug Discovery & Development (2024-2032) ($MN)
• Table 35 Global Lab-on-a-chip Market Outlook, By Genomics & Proteomics (2024-2032) ($MN)
• Table 36 Global Lab-on-a-chip Market Outlook, By Environmental Monitoring (2024-2032) ($MN)
• Table 37 Global Lab-on-a-chip Market Outlook, By Food Safety & Quality Control (2024-2032) ($MN)
• Table 38 Global Lab-on-a-chip Market Outlook, By Other Applications (2024-2032) ($MN)
• Table 39 Global Lab-on-a-chip Market Outlook, By End User (2024-2032) ($MN)
• Table 40 Global Lab-on-a-chip Market Outlook, By Hospitals & Diagnostic Centers (2024-2032) ($MN)
• Table 41 Global Lab-on-a-chip Market Outlook, By Biotechnology & Pharmaceutical Companies (2024-2032) ($MN)
• Table 42 Global Lab-on-a-chip Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
• Table 43 Global Lab-on-a-chip Market Outlook, By Forensic Laboratories (2024-2032) ($MN)
• Table 44 Global Lab-on-a-chip Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.